Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.36 USD | -3.11% | -0.38% | +13.63% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.63% | 7.76B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.08% | 21.97B | |
-5.20% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte, Lonza Sign Vaccine Manufacturing Agreement